Menu
 
Research menu
Jump to menu

Publications:  Dr Kevin Rouault-Pierre

Caye A, Rouault-Pierre K, Strullu M, Lainey E, Abarrategi A, Fenneteau O, Arfeuille C, Osman J et al.(2020). Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment. Leukemia vol. 34, (6) 1658-1668.
10.1038/s41375-019-0662-y
Waclawiczek A, Hamilton A, Rouault-Pierre K, Abarrategi A, Albornoz MG, Miraki-Moud F, Bah N, Gribben J et al.(2020). Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia. Journal of Clinical Investigation vol. 130, (6) 3038-3050.
10.1172/JCI133187
Jaud M, Philippe C, Di Bella D, Tang W, Pyronnet S, Laurell H, Mazzolini L, Rouault-Pierre K et al.(2020). Translational Regulations in Response to Endoplasmic Reticulum Stress in Cancers. Cells vol. 9, (3)
10.3390/cells9030540
Caye A, Rouault-Pierre K, Strullu M, Lainey E, Abarrategi A, Fenneteau O, Arfeuille C, Osman J et al.(2020). Correction: Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment (Leukemia, (2019), 10.1038/s41375-019-0662-y). Leukemia
10.1038/s41375-020-0720-5
Abarrategi A, Gambera S, Alfranca A, Rodriguez-Milla MA, Perez-Tavarez R, Rouault-Pierre K, Waclawiczek A, Chakravarty P et al.(2018). c-Fos induces chondrogenic tumor formation in immortalized human mesenchymal progenitor cells. Scientific Reports vol. 8, (1)
10.1038/s41598-018-33689-0
Abarrategi A, Mian SA, Passaro D, Rouault-Pierre K, Grey W, Bonnet D(2018). Modeling the human bone marrow niche in mice: From host bone marrow engraftment to bioengineering approaches. Journal of Experimental Medicine vol. 215, (3) 729-743.
10.1084/jem.20172139
Di Tullio A, Rouault-Pierre K, Abarrategi A, Mian S, Grey W, Gribben J, Stewart A, Blackwood E et al.(2017). The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia. Nat Commun vol. 8, (1) 1679-1679.
10.1038/s41467-017-01834-4
https://qmro.qmul.ac.uk/xmlui/handle/123456789/34404
Passaro D, Di Tullio A, Abarrategi A, Rouault-Pierre K, Foster K, Ariza-McNaughton L, Montaner B, Chakravarty P et al.(2017). Increased Vascular Permeability in the Bone Marrow Microenvironment Contributes to Disease Progression and Drug Response in Acute Myeloid Leukemia. Cancer Cell vol. 32, (3) 324-341.e6.
10.1016/j.ccell.2017.08.001
https://qmro.qmul.ac.uk/xmlui/handle/123456789/34506
Das A, Rouault-Pierre K, Kamdar S, Gomez-Tourino I, Wood K, Donaldson I, Mein CA, Bonnet D et al.(2017). Adaptive from Innate: Human IFN-γ+CD4+T Cells Can Arise Directly from CXCL8-Producing Recent Thymic Emigrants in Babies and Adults. J Immunol vol. 199, (5) 1696-1705.
10.4049/jimmunol.1700551
https://qmro.qmul.ac.uk/xmlui/handle/123456789/34783
Di Tullio A, Passaro D, Rouault-Pierre K, Purewal S, Bonnet D(2017). Nuclear Factor Erythroid 2 Regulates Human HSC Self-Renewal and T Cell Differentiation by Preventing NOTCH1 Activation. Stem Cell Reports vol. 9, (1) 5-11.
10.1016/j.stemcr.2017.05.027
Passaro D, Di Tullio A, Abarrategi A, Rouault-Pierre K, Foster K, Ariza-McNaughton L, Chakravarty P, Bhaw L et al. (2017). ACUTE MYELOID LEUKEMIA ALTERS THE PERMEABILITY OF THE BONE MARROW VASCULAR MICROENVIRONMENT, FOSTERING DISEASE PROGRESSION AND DRUG RESISTANCE. HAEMATOLOGICA. vol. 102, 78-78.
Rouault-Pierre K, Smith AE, Mian SA, Pizzitola I, Kulasekararaj AG, Mufti GJ, Bonnet D(2017). Myelodysplastic syndrome can propagate from the multipotent progenitor compartment. Haematologica vol. 102, (1) e7-e10.
10.3324/haematol.2016.152520
Rouault-Pierre K, Mian SA, Goulard M, Abarrategi A, Di Tulio A, Smith AE, Mohamedali A, Best S et al.(2017). Preclinical modeling of myelodysplastic syndromes. Leukemia vol. 31, (12) 2702-2708.
10.1038/leu.2017.172
Passaro D, Di Tullio A, Abarrategi A, Rouault-Pierre K, Foster K, McNaughton LA, Lassailly F, Bonnet D (2016). Increased Vascular Permeability in the Bone Marrow Microenvironment Contributes to Acute Myeloid Leukemia Progression and Drug Response. BLOOD. vol. 128,
10.1182/blood.V128.22.2662.2662
Rouault-Pierre K, Hamilton A, Bonnet D(2016). Effect of hypoxia-inducible factors in normal and leukemic stem cell regulation and their potential therapeutic impact. Expert Opinion on Biological Therapy vol. 16, (4) 463-476.
10.1517/14712598.2016.1133582
Mian SA, Rouault-Pierre K, Smith AE, Seidl T, Pizzitola I, Kizilors A, Kulasekararaj AG, Bonnet D et al.(2015). SF3B1 mutant MDS-initiating cells may arise from the haematopoietic stem cell compartment. Nature Communications vol. 6,
10.1038/ncomms10004
Foster K, Lassailly F, Anjos-Afonso F, Currie E, Rouault-Pierre K, Bonnet D(2015). Different motile behaviors of human hematopoietic stem versus progenitor cells at the osteoblastic niche. Stem Cell Reports vol. 5, (5) 690-701.
10.1016/j.stemcr.2015.09.003
Tettamanti S, Pizzitola I, Marin V, Anjos-Afonso F, Rouault-Pierre K, Lassailly F, Spinelli O, Biondi A et al. (2015). Chimeric Antigen Receptors for Specific Targeting of Acute Myeloid Leukemia. ANNALS OF HEMATOLOGY. vol. 94, S55-S56.
Das A, Furness C, White A, Hayday T, Rouault-Pierre K, Greaves M, Hayday AC, Gibbons DL (2014). T-cell production of interleukin-8 (CXCL8) is enriched in recent thymic emigrants. IMMUNOLOGY. vol. 143, 46-47.
Pizzitola I, Anjos-Afonso F, Rouault-Pierre K, Lassailly F, Tettamanti S, Biondi A, Biagi E, Bonnet D (2014). Chimeric Antigen Receptor for Specific Targeting of Acute Myeloid Leukaemia. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. vol. 36, 324-325.
Griessinger E, Anjos-Afonso F, Pizzitola I, Rouault-Pierre K, Vargaftig J, Taussig D, Gribben J, Lassailly F et al.(2014). A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: A new tool to decipher their chemoresistance and self-renewal mechanisms. Stem Cells Translational Medicine vol. 3, (4) 520-529.
10.5966/sctm.2013-0166
Pizzitola I, Anjos-Afonso F, Rouault-Pierre K, Lassailly F, Tettamanti S, Spinelli O, Biondi A, Biagi E et al.(2014). Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo. Leukemia vol. 28, (8) 1596-1605.
10.1038/leu.2014.62
Mian SA, Rouault-Pierre K, Smith AE, Seidl T, Kulasekararaj AG, Mohamedali AM, Shinde S, Bonnet D et al. (2013). SF3B1 Mutant Clones From Patients With Refractory Anaemia With Ringed Sideroblasts (RARS) Originate From The Early Haematopoietic Stem Cells and Maintain Their Engraftment Potential. BLOOD. vol. 122,
Rouault-Pierre K, Lopez-Onieva L, Foster K, Anjos-Afonso F, Lamrissi-Garcia I, Serrano-Sanchez M, Mitter R, Ivanovic Z et al.(2013). HIF-2α Protects Human Hematopoietic Stem/Progenitors and Acute Myeloid Leukemic Cells from Apoptosis Induced by Endoplasmic Reticulum Stress. Cell Stem Cell vol. 13, (5) 549-563.
10.1016/j.stem.2013.08.011
Rouault-Pierre K, Lopez-Onieva L, Foster K, Anjos-Afonso F, Lamrissi-Garcia I, Serrano-Sanchez M, Mitter R, Ivanovic Z et al.(2013). HIF-2α Protects Human Hematopoietic Stem/ Progenitors and Acute Myeloid Leukemic Cells from Apoptosis Induced by Endoplasmic Reticulum Stress. Cell Stem Cell
10.1016/j.stem.2013.08.011
Pizzitola I, Anjos-Afonso F, Rouault-Pierre K, Lassailly F, Tettamanti S, Biondi A, Biagi E, Bonnet D (2013). CHIMERIC ANTIGEN RECEPTOR FOR SPECIFIC TARGETING OF ACUTE MYELOID LEUKAEMIA. PEDIATRIC BLOOD & CANCER. vol. 60, 29-29.
Pizzitola I, Anjos-Afonso F, Rouault-Pierre K, Lassailly F, Biondi A, Biagi E, Bonnet D (2013). CHIMERIC ANTIGEN RECEPTOR FOR SPECIFIC TARGETING OF ACUTE MYELOID LEUKEMIA. CYTOTHERAPY. vol. 15, S53-S53.
10.1016/j.jcyt.2013.01.205
Pizzitola I, Anjos-Afonso F, Rouault-Pierre K, Lassailly F, Tettamanti S, Biondi A, Biagi E, Bonnet D (2012). Chimeric Antigen Receptor for Specific Targeting of Acute Myeloid Leukemia. BLOOD. vol. 120,
10.1182/blood.V120.21.4225.4225
Rouault-Pierre K, Lopez-Onieva L, Rezvani H, Anjos-Afonso F, Lamrissi-Garcia I, Vlaski M, De Verneuil H, Ivanovic Z et al. (2012). HYPOXIA-INDUCIBLE FACTOR 1A IS IMPORTANT TO MAINTAIN HUMAN HSC, BUT HIF-2A IS ESSENTIAL TO PROTECT THEM FROM ROS INDUCED APOPTOSIS. EXPERIMENTAL HEMATOLOGY. vol. 40, S102-S103.
Return to top